Eupraxia Pharmaceuticals, Inc.
EPRX · TSX · CAD
CA$9.27
−0.09 −0.96%todayNot financial advice.
- Open
- 9.60
- Day range
- 9.27 - 9.68
- 52-week range
- 7.35 - 13.08
- Volume
- 16.72K
- Market cap
- 433.05M
- P/E ratio
- —
- EPS
- -0.96
- Dividend yield
- 0.00%
- Beta
- 1.23
Performance
W
−15.73%
1M
−18.33%
3M
+7.17%
6M
−7.58%
YTD
−10.35%
Y
+9.96%
5Y
+228.72%
All
+19.61%
In the news
Oct 15
Eupraxia Pharmaceuticals Hits Target in RESOLVE Clinical Trial
Eupraxia Pharmaceuticals completed enrollment for its RESOLVE trial testing EP-104GI, with interim Phase 2b data expected in December 2026.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/TSX-EPRX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Eupraxia Pharmaceuticals, Inc. (EPRX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/TSX-EPRX">EPRX stock price</a> by FreeTheAI Stocks</p>